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Endoscopic treatment for benign biliary strictures (BBSs) has
been widely accepted. However, for refractory strictures, espe-
cially for hilar anastomotic strictures after living-donor liver
transplants and hepaticojejunostomies, endoscopic treatment
remains a challenge. The hilar location, with its small caliber
ducts, can complicate the insertion of multiple plastic stents.
The use of fully covered self-expandable metal stents
(FCSEMSs) may be an attractive option in this setting, but this
had not, to date, been properly investigated.
“Treating hilar refractory postoperative
strictures is challenging, but the present study
shows that treatment with FCSEMS is feasible
when appropriate measures are taken to
prevent complications.”
Larger diameter stents seem to facilitate durable stricture reso-
lution. Therefore, treatment with multiple (cumulatively inser-
ted) plastic stents has been widely adopted [1]. Over the last
decade, with the introduction of FCSEMSs, which are specifical-
ly designed and equipped to allow for removal, the horizon for
the application of metal stents in benign disease has expanded.
With their large bore diameter, they may offer effective treat-
ment with fewer re-interventions.
In 2014, a large multicenter study involving 187 distal BBSs,
with a variety of etiologies, treated with FCSEMSs placed in a
transpapillary fashion was published [2, 3]. FCSEMSs were inser-
ted for 10–12 months in patients with chronic pancreatitis or
cholecystectomy, and for 4–6 months in patients who were
post orthotopic liver transplant; 75% could be successfully re-
moved and stricture resolution was achieved in 71% of these
cases. After a median follow-up of 20 months, 15% of the stric-
tures recurred. Serious adverse events, mostly cholangitis, oc-
curred in 27% of patients. Interestingly, specifically in the liver
transplant group, the migration rate was high at up to 75%
after 6 months.
Recently, the first three randomized controlled trials were
published on plastic versus metal stenting for BBSs [4–6]. To-
gether, they studied 222 patients, mostly suffering from ana-
stomotic strictures after orthotopic liver transplant. After 6
months of FCSEMS placement, stricture resolution rates ranged
from 75%–88% and recurrence rates from 22%–32%. Compli-
cations occurred in 23%–50%, but were mostly mild. Migration
rates varied widely, from 10% to 95%.
In living-donor liver transplant, the biliary anastomosis is
more peripheral, smaller, and more complex than after an or-
thotopic transplant. Therefore, these results may not be applic-
able to living-donor recipients or patients with other hilar stric-
tures, such as post-hepaticojejunostomy. In this issue of the
journal, Tatsuya Sato et al. address this specific group [7].
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They present a single-center Japanese study aimed at evaluat-
ing the use of FCSEMSs for mostly hilar BBSs. They prospectively
treated 29 patients, almost exclusively suffering from post-
operative strictures, in whom 6 months of prior plastic stenting
had failed, using 90 days of FCSEMS indwelling. Outcomes were
remarkably good, considering the short treatment duration
and the (well-defined) rescue setting, with a 97% stricture reso-
lution rate, 11% recurrence rate after a median of 15 months,
and 10% adverse event rate. The authors conclude that tem-
porary placement of an FCSEMS is a feasible and effective treat-
ment option for refractory BBSs, especially for hilar strictures.
Their low complication rate seems to be explained by a com-
bination of techniques that they applied. In post-hepaticojeju-
nostomy strictures, FCSEMSs were placed using a double-bal-
loon endoscope. Furthermore, routine balloon dilation, but
not sphincterotomy, was applied. Cholangitis and stent kinking
were prevented by (eventually) routine placement of a second
plastic stent, side-by-side as a “rescue” to prevent segmental
cholangitis, or inside the SEMS as a “core” to prevent kinking.
In addition, the short indwelling time likely contributed to the
low stent occlusion rate and prevented stent removal prob-
lems. Given the excellent stricture resolution rate, 3 months of
treatment may be sufficient, despite it being much shorter
than previously advocated. In other studies, indwelling times
have ranged from 6 to 12 months and Devière et al. recommen-
ded 4–6 months in 2014 [2].
While these results are promising, they should be put into
the context of a few limitations. Most importantly, the reported
follow-up may be too short to allow for strictures to recur, given
the results of other studies showing that recurrences occur be-
tween 13–21 months. Second, these results seem to apply to
postoperative strictures only, as chronic pancreatitis or other
causes were hardly studied. Also, the studied postoperative
strictures form a heterogeneous group.
Treating hilar refractory postoperative strictures is challen-
ging, but the present study shows that treatment with
FCSEMSs is feasible when appropriate measures are taken to
prevent complications. It seems safe and effective and may
provide a chance to reduce treatment duration and interven-
tions, which would benefit the patient and treating physician
alike. For this reason, a head-to-head prospective comparison
between plastic and metal stenting in this setting is eagerly
awaited. Stent migration remains a concern and should be a fo-
cus for future developments. Ideally, a migration-resistant
stent that degrades spontaneously will be developed.
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